Q3 2024 saw a sharp year-over-year revenue and profit decline due to lower lithium prices and reduced investment income, but sales volumes of lithium compounds rose. Losses narrowed sequentially as cost structure improved, and new capacity ramp-up supports future growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.